Biological Process
| muscle contraction | | TAS | | 2290271 | PMID:8387489 | PINC | PMID:8387489 |
| transport | | TAS | | 2290271 | PMID:8387489 | PINC | PMID:8387489 |
Cellular Component
| voltage-gated calcium channel complex | | IEA | InterPro:IPR005421 | 2290271 | GO_REF:0000002 | InterPro | GO_REF:0000002 |
Molecular Function
| voltage-gated calcium channel activity | | IEA | InterPro:IPR005421 | 2290271 | GO_REF:0000002 | InterPro | GO_REF:0000002 |
| 1298468 | BP34_H | Blood pressure QTL 34 (human) | 2.16 | | Blood pressure | systolic | 17 | 623167 | 66547903 | Human |
| 1331651 | COPD12_H | Chronic obstructive pulmonary disease QTL 12 (human) | 2.44 | | Chronic airflow obstruction | post-bronchodilator FEV1/FVC | 17 | 10859378 | 66547903 | Human |
| 1559242 | FBRL6_H | Fibrinogen level QTL 6 (human) | 1.5 | | Fibrinogen level | | 17 | 10859378 | 80253028 | Human |
| 1559256 | SCL59_H | Serum cholesterol level QTL 59 (human) | 2.48 | | Lipid level | total cholesterol | 17 | 16064515 | 80253028 | Human |
| 1298421 | BP35_H | Blood pressure QTL 35 (human) | | .0001 | Blood pressure | hypertension susceptibility | 17 | 36852911 | 68465676 | Human |
| 1643075 | BP89_H | Blood pressure QTL 89 (human) | 3.22 | .000059 | Blood pressure | | 17 | 38994411 | 72681088 | Human |
| 2292952 | PRSTS193_H | Prostate tumor susceptibility QTL 193 (human) | 4.51 | .0045 | Prostate tumor susceptibility | | 17 | 40282159 | 66282159 | Human |
| 2292953 | PRSTS184_H | Prostate tumor susceptibility QTL 184 (human) | 5.82 | .0053 | Prostate tumor susceptibility | | 17 | 40282159 | 66282159 | Human |
| 2292963 | PRSTS178_H | Prostate tumor susceptibility QTL 178 (human) | 6.18 | .0033 | Prostate tumor susceptibility | | 17 | 40282159 | 66282159 | Human |
| 2292979 | PRSTS186_H | Prostate tumor susceptibility QTL 186 (human) | 5.75 | .0079 | Prostate tumor susceptibility | | 17 | 40282159 | 66282159 | Human |
| 2292991 | PRSTS133_H | Prostate tumor susceptibility QTL 133 (human) | 2.56 | .01 | Prostate tumor susceptibility | | 17 | 40282159 | 66282159 | Human |
| 2292999 | PRSTS179_H | Prostate tumor susceptibility QTL 179 (human) | 6.18 | .0033 | Prostate tumor susceptibility | | 17 | 40282159 | 66282159 | Human |
| 2293008 | PRSTS188_H | Prostate tumor susceptibility QTL 188 (human) | 6.06 | .0029 | Prostate tumor susceptibility | | 17 | 40282159 | 66282159 | Human |
| 2292927 | PRSTS191_H | Prostate tumor susceptibility QTL 191 (human) | 4.13 | .0018 | Prostate tumor susceptibility | | 17 | 40282159 | 66282159 | Human |
| 2292933 | PRSTS182_H | Prostate tumor susceptibility QTL 182 (human) | 5.44 | .0026 | Prostate tumor susceptibility | | 17 | 40282159 | 66282159 | Human |
| 2292944 | PRSTS180_H | Prostate tumor susceptibility QTL 180 (human) | 6.18 | .0065 | Prostate tumor susceptibility | | 17 | 40282159 | 66282159 | Human |
| 2289501 | BW444_H | Body weight QTL 444 (human) | 2.83 | | Body weight | BMI | 17 | 43331542 | 69331542 | Human |
| 2289511 | BW453_H | Body weight QTL 453 (human) | 2.15 | | Body fat amount | abdominal | 17 | 43331542 | 69331542 | Human |
| 1643462 | BW108_H | Body weight QTL 108 (human) | 2.24 | .0007 | Body fat amount | abdominal visceral | 17 | 46673110 | 72673110 | Human |
| 2292917 | PRSTS128_H | Prostate tumor susceptibility QTL 128 (human) | 2.2 | | Prostate tumor susceptibility | | 17 | 48436413 | 74436413 | Human |
| 1578616 | LDLPS6_H | Low density lipoprotein particle size QTL 6 (human) | 4.7 | .000001 | LDL particle size | | 17 | 52798864 | 70672324 | Human |
| 1578621 | LDLPS7_H | Low density lipoprotein particle size QTL 7 (human) | 4.72 | .000001 | LDL particle size | | 17 | 52798864 | 70672324 | Human |
| 1578623 | LDLPS5_H | Low density lipoprotein particle size QTL 5 (human) | 6.76 | .000001 | LDL particle size | | 17 | 52798864 | 70672324 | Human |
| 2289263 | BW92_H | Body weight QTL 92 (human) | .1 | 3.16 | Body weight | BMI | 17 | 53282084 | 71998115 | Human |
| 1298461 | BP20_H | Blood pressure QTL 20 (human) | | .0256 | Blood pressure | hypertension susceptibility | 17 | 53547832 | 79547832 | Human |
| 1581525 | BP63_H | Blood pressure QTL 63 (human) | 3.6 | .001 | Blood pressure | pulse pressure | 17 | 53547832 | 79547832 | Human |
| 1298465 | BP14_H | Blood pressure QTL 14 (human) | 1.9 | .0029 | Blood pressure | hypertension susceptibility | 17 | 55465561 | 81465561 | Human |
| 1643448 | BW109_H | Body weight QTL 109 (human) | 1.53 | .004 | Body fat amount | abdominal visceral | 17 | 56331449 | 82331449 | Human |
| 1298512 | RA29_H | Rheumatoid arthritis QTL 29 (human) | | .0017 | Joint/bone inflammation | rheumatoid arthritis | 17 | 59681011 | 85681011 | Human |
| 1643091 | BP90_H | Blood pressure QTL 90 (human) | 1.5 | .0043 | Blood pressure | | 17 | 59681011 | 85681011 | Human |
| 1643267 | SADIPOQ6_H | Serum adiponectin level QTL 6 (human) | 1.32 | | Hormone level | serum adiponectin level | 17 | 59681011 | 85681011 | Human |
| 1643284 | BW332_H | Body Weight QTL 332 (human) | 1.41 | .005 | Body weight | body mass index | 17 | 59681011 | 85681011 | Human |
| 2289618 | BW487_H | Body weight QTL 487 (human) | 1.44 | | Body weight | BMI | 17 | 59681011 | 85681011 | Human |
| 2316339 | GLUCO234_H | Glucose level QTL 234 (human) | 1.29 | | Glucose level | | 17 | 59681011 | 85681011 | Human |
| 2315441 | INSUL42_H | Insulin level QTL 42 (human) | 3.2 | .0012 | Insulin level | | 17 | 61431471 | 87431471 | Human |
| 2315444 | GLUCO140_H | Glucose level QTL 140 (human) | 2.38 | .0087 | Glucose level | | 17 | 61431471 | 87431471 | Human |
| 1643051 | BW116_H | Body Weight QTL 116 (human) | 2.48 | .00036 | Body weight | | 17 | 64802303 | 90802303 | Human |
| 1643572 | GLUCO9_H | Glucose level QTL 9 (human) | 1.6 | | Glucose level | non-insulin-dependent | 17 | 64802303 | 90802303 | Human |
| 2314710 | GLUCO61_H | Glucose level QTL 61 (human) | 1.74 | .576 | Glucose level | insulin sensitivity | 17 | 64802303 | 90802303 | Human |
| 2289203 | BW364_H | Body weight QTL 364 (human) | | .0463 | Body fat amount | percent fat | 17 | 64802303 | 90802303 | Human |